Evidence map›Paper›PMID 31689965›Full record

ArticleGenes2019

PipeMEM: A Framework to Speed Up BWA-MEM in Spark with Low Overhead.

Lingqi Zhang, Cheng Liu, Shoubin Dong

Abstract read
In one paragraph

Article in Genes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lingqi ZhangCommunication & Computer Network Lab of Guangdong, School of Computer Science & Engineering, South China University of Technology, Wushan Road 381, Guangzhou 51000, China. cslingqizhang@gmail.com.ORCID 0000-0002-2452-1551
Cheng LiuCommunication & Computer Network Lab of Guangdong, School of Computer Science & Engineering, South China University of Technology, Wushan Road 381, Guangzhou 51000, China. ztcattlepatato@gmail.com.
Shoubin DongCommunication & Computer Network Lab of Guangdong, School of Computer Science & Engineering, South China University of Technology, Wushan Road 381, Guangzhou 51000, China. sbdong@scut.edu.cn.ORCID 0000-0003-0153-850X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: DNA sequence alignment process is an essential step in genome analysis. BWA-MEM has been a prevalent single-node tool in genome alignment because of its high speed and accuracy. The exponentially generated genome data requiring a multi-node solution to handle large volumes of data currently remains a challenge. Spark is a ubiquitous big data platform that has been exploited to assist genome alignment in handling this challenge. Nonetheless, existing works that utilize Spark to optimize BWA-MEM suffer from higher overhead. (2) Methods: In this paper, we presented PipeMEM, a framework to accelerate BWA-MEM with lower overhead with the help of the pipe operation in Spark. We additionally proposed to use a pipeline structure and in-memory-computation to accelerate PipeMEM. (3) Results: Our experiments showed that, on paired-end alignment tasks, our framework had low overhead. In a multi-node environment, our framework, on average, was 2.27× faster compared with BWASpark (an alignment tool in Genome Analysis Toolkit (GATK)), and 2.33× faster compared with SparkBWA. (4) Conclusions: PipeMEM could accelerate BWA-MEM in the Spark environment with high performance and low overhead.

Indexed as

AlgorithmsBig DataChromosome MappingGenome, HumanHigh-Throughput Nucleotide SequencingHumansSequence AlignmentSequence Analysis, DNASoftwareBWA-MEMlow overheadSpark

Identifiers

PMID31689965
PMCPMC6896194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.